Controlled studies show TPE lowers triglycerides only moderately faster than conservative treatment within 24 hours, with no definitive data on improved clinical outcomes.
BMC Gastroenterology · 1 author, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Controlled studies show TPE lowers triglycerides only moderately faster than conservative treatment within 24 hours, with no definitive data on improved clinical outcomes.
This narrative review evaluates the evidence for TPE and insulin in HTG-AP. HTG accounts for about 2–10% of AP cases generally and up to 28–48% during pregnancy. Controlled studies consistently show TPE achieves approximately 70% triglyceride reduction versus approximately 50% with conservative treatment within 24 hours. This moderate difference is unlikely to be clinically significant in most patients. Limited non-randomized data show no improvement in clinical outcomes with TPE. Neither TPE nor insulin has definitive randomized evidence of efficacy on clinical endpoints. The author suggests TPE may be considered in severe HTG-AP when triglyceride decline with conservative treatment is insufficient, and in HTG-AP during pregnancy. Results from the ongoing ELEPHANT randomized trial are expected to clarify the respective roles of these treatments.